RVTY

THE SECTION ON MEDICINAL CHEMISTRY DEVELOPS NEW MOLECULAR ENTITIES WITH IMPLACTION IN IMPROVING HEALTH AND TREATMENT FOR VARIOUS METABOLIC DIESEASES. TO ASSESS THE TRANSLATIONAL POTENTIAL OF NOVEL MOLECULAR ENTITIES, WHICH WOULD ALLOW US TO MAKE DECI

NIDA: SUPPLY: UNIFILTER-96 CELL HARVESTER 55: N/A

CMT-ASD. CELLOMETER ASCEND AUTOMATED CELL COUNTER. REFERENCE QUOTE Q-135389

COMPLETE SERVICE AGREEMENT FOR TWO (2) OPERETTA CLS HIGH-CONTENT IMAGING SYSTEMS , SIX (6) OPERA PHENIX CONFOCAL MICROSCOPY SYSTEMS, AND ASSOCIATED INTEGRATED EQUIPMENT

BASE AND 1 OPTION YEAR SERVICE AND MAINTENANCE OF REVVITY OPERA PHENIX PLUS SYSTEM MICROSCOPE

REPAIR OF IVIS CT SYSTEM

MAINTENANCE AGREEMENT FOR EQUIPMENT MAINTENANCE AND CUSTOMER SUPPORT.

REVVITY SCICLONE/ZEPHYR PMA

Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act Support for Genetic Screening Proposals related to pandemic preparedness

Diagnostic test reimbursement and policies Genomic sequencing Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs

Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Newborn Screening Saves Lives Act Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs Medical Device & Pharmaceutical Adjacent Tariff

Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariff

SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs. SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs. SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T

Diagnostic test reimbursement and policies; Proposals related to newborn screening; Proposals related to pandemic preparedness; H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses